Grifols secured a $21 million grant from the Michael J. Fox Foundation to study plasma biomarkers for early Parkinson’s detection. The 10-year Chronos PD project will...
The approval of the treatment is based on two pivotal phase III clinical trials: M15-741 and M-15-736. Primary endpoint results from the first trial showed that...